Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐19). Early anecdotal reports and limited in vitro data led to the significant uptake of hydroxychloroquine (HCQ), and to lesser extent chloroquine (CQ), for many patients with this disease. As an increasing numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyerowitz, Eric A., Vannier, Augustin G. L., Friesen, Morgan G. N., Schoenfeld, Sara, Gelfand, Jeffrey A., Callahan, Michael V., Kim, Arthur Y., Reeves, Patrick M., Poznansky, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267640/
https://www.ncbi.nlm.nih.gov/pubmed/32350928
http://dx.doi.org/10.1096/fj.202000919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267640/
https://www.ncbi.nlm.nih.gov/pubmed/32350928
http://dx.doi.org/10.1096/fj.202000919

Ejemplares similares